Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 05 02:09PM ET
5.90
Dollar change
+0.18
Percentage change
3.15
%
Index- P/E- EPS (ttm)-16.23 Insider Own8.32% Shs Outstand0.82M Perf Week-6.35%
Market Cap4.84M Forward P/E24.58 EPS next Y0.24 Insider Trans0.00% Shs Float0.75M Perf Month9.67%
Income-6.53M PEG- EPS next Q-0.38 Inst Own26.92% Short Float3.47% Perf Quarter11.95%
Sales7.53M P/S0.64 EPS this Y91.34% Inst Trans28.23% Short Ratio0.06 Perf Half Y4.61%
Book/sh3.63 P/B1.63 EPS next Y109.92% ROA-61.83% Short Interest0.03M Perf Year-58.68%
Cash/sh11.20 P/C0.53 EPS next 5Y40.00% ROE-407.60% 52W Range3.54 - 17.88 Perf YTD-53.19%
Dividend Est.- P/FCF- EPS past 5Y15.68% ROI-244.97% 52W High-67.00% Beta0.22
Dividend TTM- Quick Ratio1.22 Sales past 5Y1418.11% Gross Margin96.97% 52W Low66.67% ATR (14)0.86
Dividend Ex-Date- Current Ratio1.28 EPS Y/Y TTM42.97% Oper. Margin-82.60% RSI (14)55.45 Volatility12.70% 12.38%
Employees4 Debt/Eq1.88 Sales Y/Y TTM110.79% Profit Margin-86.75% Recom1.00 Target Price18.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q86.14% Payout- Rel Volume0.44 Prev Close5.72
Sales Surprise-14.38% EPS Surprise-29.17% Sales Q/Q125.51% EarningsAug 13 BMO Avg Volume414.20K Price5.90
SMA205.92% SMA5018.80% SMA200-4.00% Trades Volume132,351 Change3.15%
Date Action Analyst Rating Change Price Target Change
Jun-22-20Upgrade H.C. Wainwright Neutral → Buy $10
Mar-05-19Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18Reiterated B. Riley FBR, Inc. Buy $10 → $5
Oct-19-17Resumed FBR & Co. Buy $10
Mar-16-17Reiterated Rodman & Renshaw Buy $6 → $9
Jan-30-17Upgrade Laidlaw Neutral → Buy $8
Jan-05-17Upgrade Rodman & Renshaw Neutral → Buy $2.50 → $6
Dec-23-16Reiterated Rodman & Renshaw Neutral $2 → $2.50
Jul-19-16Reiterated FBR Capital Outperform $17 → $9
Jul-19-16Downgrade Noble Financial Buy → Hold
Oct-28-24 01:39PM
07:00AM
Oct-23-24 08:30AM
Oct-22-24 08:30AM
Oct-01-24 08:30AM
02:38AM Loading…
Sep-21-24 02:38AM
Sep-19-24 02:20PM
Sep-09-24 08:30AM
Sep-04-24 09:20AM
Aug-13-24 08:00AM
Aug-08-24 08:30AM
Jul-30-24 08:30AM
Jun-17-24 08:30AM
May-16-24 04:02PM
May-14-24 10:53PM
04:15PM Loading…
04:15PM
Apr-17-24 08:30AM
Mar-21-24 04:15PM
Mar-15-24 01:58PM
06:56AM
Mar-14-24 04:05PM
Mar-07-24 04:10PM
Feb-14-24 07:30AM
Feb-09-24 07:30AM
Nov-30-23 12:16PM
Nov-27-23 08:30AM
Nov-14-23 08:30AM
Nov-09-23 08:30AM
Oct-31-23 08:30AM
Oct-23-23 06:30AM
08:30AM Loading…
Oct-18-23 08:30AM
Sep-14-23 08:30AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
Jul-25-23 08:30AM
Jun-14-23 08:30AM
May-15-23 04:05PM
May-09-23 07:00AM
May-04-23 08:30AM
May-01-23 08:30AM
Apr-20-23 08:30AM
Apr-06-23 08:30AM
Mar-24-23 07:36AM
Mar-23-23 08:30AM
Mar-21-23 04:05PM
Mar-15-23 08:30AM
Feb-21-23 07:00AM
Jan-30-23 07:00AM
Jan-18-23 08:30AM
Dec-07-22 08:30AM
Nov-30-22 08:30AM
Nov-12-22 08:03AM
Nov-09-22 04:30PM
04:05PM
Nov-02-22 08:30AM
Oct-20-22 08:44AM
Sep-20-22 08:30AM
Sep-14-22 08:30AM
Sep-06-22 08:30AM
Aug-16-22 08:30AM
Aug-10-22 04:30PM
04:05PM
Aug-03-22 08:30AM
Aug-01-22 08:30AM
Jul-06-22 08:30AM
Jun-15-22 08:30AM
Jun-08-22 08:30AM
May-23-22 07:00AM
May-18-22 08:30AM
May-17-22 08:30AM
May-10-22 04:05PM
May-03-22 08:30AM
Apr-26-22 11:36AM
08:54AM
08:30AM
Apr-19-22 08:30AM
Mar-10-22 08:30AM
Mar-08-22 04:05PM
Mar-01-22 08:30AM
Feb-24-22 08:30AM
Feb-17-22 08:30AM
Feb-02-22 08:30AM
Jan-04-22 08:30AM
Nov-10-21 04:05PM
Nov-03-21 08:30AM
Oct-20-21 08:30AM
Sep-29-21 08:30AM
Sep-10-21 07:53AM
Sep-01-21 08:30AM
Aug-16-21 07:20AM
Aug-12-21 04:05PM
Aug-05-21 08:30AM
Aug-02-21 08:30AM
Jul-14-21 08:30AM
Jun-29-21 08:30AM
Jun-15-21 08:30AM
Jun-08-21 08:30AM
Jun-02-21 08:30AM
May-27-21 08:30AM
May-14-21 08:30AM
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.